Canadian Urological Association / L'Association des urologues du Canada

Canadian Urological Association (CUA)

Health EN ↓ Odcinki: 102

The official podcast of the Canadian Urological Association (CUA).Le podcast officiel de l'association des urologues du Canada (AUC).

Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: cua.simplecast.com

Autor

Canadian Urological Association / L'Association des urologues du Canada

Kategoria

Health

Strona podcastu

cua.simplecast.com

Ostatni odcinek

4 mar 2025

Gdzie słuchać?

Podcasty w aplikacji Replaio Radio Już wkrótce

Podcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów

Pobierz z Google Play Zainstaluj za darmo Android prawie 10 mln pobrań · ocena 4,8 iOS niedługo

Odcinki

CUA Highlights of GU ASCO 2022 - Prostate Cancer Session - French 22.02.2022

Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position Tamim Niazi Honoraria/ research funding: Abbvie, Astellas, Bayer, Janssen, Sanofi, Merck, AstraZeneca, TerSera, Knight Therapeutics, Amgen, Tolm...

CUA Highlights of GU ASCO 2022 - Kidney Cancer Session - French 22.02.2022

Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position Christian Kollmannsberger Consultant: Pfizer, Merck, Sanofi, Astellas, BMS, Ipsen, Eisai, Bayer Honoraria for presentations: Pfizer, Ipsen, Eisa...

CUA Highlights of GU ASCO 2022 - Bladder Cancer Session - French 22.02.2022

Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position Nimira Alimohamed Advisory Board/Consultancy roles: Pfizer, EMD Serono, Merck, Seagen Wassim Kassouf No disclosures Alejandro Berlin No disclosu...

CUA Practice Changing Publications (PCP) - Endourology (Surgical Management of BPH) 15.02.2022

Disclosures: Dean Elterman Advisory Boards/ Speakers Bureaus: Astellas, Boston Scientific, Duchesnay, Pfizer, Procept, Prodeon, Olympus, Medtronic, Urotronic, Zeneflow Kevin Zorn Advisory Board: BSCI, Procept, Zenflow

V2P2 2022 - An Update in Advanced Prostate Cancer 10.02.2022

Disclosures: Fred Saad Grants/Honoraria: Amgen, Astellas, AstraZeneca, Bayer, Merck, Novartis, Janssen, Myovant, Sanofi Eleni Efstathiou Research Support/P.I.: Janssen, Sanofi-Genzyme, Astellas/Medivation, Oric-Pharma, Nuvation Scientific Advisory Board/Honoraria: Janssen, Sanofi-Genzyme, Bayer, Oric Pharma, Marck, AAA-Novartis, Genetech, Astra-Zeneca, Astellas, Pfizer, Myovant

V2P2 2022 - An Update in Advanced Prostate Cancer - French 10.02.2022

Disclosures: Fred Saad Grants/Honoraria: Amgen, Astellas, AstraZeneca, Bayer, Merck, Novartis, Janssen, Myovant, Sanofi Eleni Efstathiou Research Support/P.I.: Janssen, Sanofi-Genzyme, Astellas/Medivation, Oric-Pharma, Nuvation Scientific Advisory Board/Honoraria: Janssen, Sanofi-Genzyme, Bayer, Oric Pharma, Marck, AAA-Novartis, Genetech, Astra-Zeneca, Astellas, Pfizer, Myovant 

Practice Changing Publications (PCP): Update in Kidney Cancer 01.02.2022

Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position: Kidney Cancer Canada Luke Lavallee Advisory Board: Sanofi, Ferring, Knight, Bayer, Janssen, Astellas Grant/Honorarium: Sanofi

The Year Ahead 2022: Global Economic Outlook 24.01.2022

Disclosures: Derek Henderson Banking relationship with TD Christopher French Advisory Boards: Astellas, AstraZeneca

Practice Changing Publications (PCP): Female Urology 07.12.2021

Disclosures: Martine Jolivet Advisory Board and/or Speaker Bureau: Allergan/Abbvie Genevieve Nadeau Clinical Trials: Contiform International Advisory Board and/or Speaker Bureau: Pfizer, Boston Scientific, Astellas, Allergan/Abbvie, Searchlight Pharma

Management of Medication-Refractory Overactive Bladder (OAB) - French 24.11.2021

Disclosures: Kevin Carlson Advisroy Board/Payment: Abbvie Richard Baverstock Advisory Board: Abbvie Speakers Bureau: Astellas, Boston Scientific, Abbvie Payment: Abbvie, Astellas, Bsci Greg Baily Advisory Board/ Speaker Bureau: Abbvie

Management of Medication-Refractory Overactive Bladder (OAB) 24.11.2021

Disclosures: Kevin Carlson Advisory Board/Payment: Abbvie Richard Baverstock Advisory Board: Abbvie Speakers Bureau: Astellas, Boston Scientific, Abbvie Payment: Abbvie, Astellas, Bsci Greg Baily Advisory Board/ Speaker Bureau: Abbvie

Precision Medicine in Prostate Cancer: Multidisciplinary Perspectives in Identifying, Managing and Optimizing Patient Care (English) 18.11.2021

Disclosures: Neil Fleshner Payment: Astellas, Janssen, Abbvie, Sanofi, Merck Grant/Honorarium: Astellas, Janssen, Bayer Investments: Verity Pharma Clinical Trials: Astellas, Janssen, Bayer Leadership Position: Point Biopharma Urban Emmenegger Advisory Boards: Amgen, Astellas, Bayer, Ferring, Janssen, Sanofi, Merck, AstraZeneca Payment: Astellas, Bayer, Ferring, Janssen, Sanofi, Merck, AstraZeneca...

Precision Medicine in Prostate Cancer: Multidisciplinary Perspectives in Identifying, Managing and Optimizing Patient Care (French) 17.11.2021

Conflits d'interests: Fred Saad Subventions/honoraires: Amgen, Astellas, AstraZeneca, Bayer, Merck, Novartis, Janssen, Myovant, Sanofi Zineb Hamilou Remuneration: AstraZeneca, Sengen, EMD Serono Essai Clinique: Sengen Evan Weber Subventions ou des honoraires: AstraZeneca/Merck

V2P2 2022 - Female Sexual Dysfunction [FR] 15.11.2021

Disclosures: Ashley Cox Advisory Board: Abbvie, Allergan Rachel S. Rubin Speakers Bureau: Sprout Clinical Trials: Ipsen, Abbvie Leadership/Board Position: ISSWSH

V2P2 2022 - Female Sexual Dysfunction 15.11.2021

Disclosures: Ashley Cox Advisory Board: Abbvie, Allergan Rachel S. Rubin Speakers Bureau: Sprout Clinical Trials: Ipsen, Abbvie Leadership/Board Position: ISSWSH

CUA Practice Changing Publications (PCP): TESTIS CANCER 02.11.2021

Disclosures: Armin Aprikian Advisory boards: Abbvie, Astellas, Bayer Grant/Honorarium: Abbvie, Astellas, Bayer, Sanofi, TerSera Robert Hamilton Advisory boards: Janssen, Astellas, Bayer, TerSera Clinical Trials: Janssen, Bayer, Astellas

CUA Practice Changing Publications (PCP): INFERTILITY 19.10.2021

Disclosures: Armand Zini Shareholder in YAD Tech - a neutraceuticals company Jesse Ory No disclosures

CUA Highlights of ESMO 2021 - Prostate Cancer Session - French 22.09.2021

Disclosures:   Sebastien J. Hotte Research Funding (Institution): Astellas, AstraZeneca, Ayala, Bayer, BMS, Eisai, Exelixis, Janssen, Ipsen, Merck, Roche, Sanofi, SeaGen, SignalChem Grants (Institution): BMS, Janssen, Bayer Consultant/Honoraria (Self): Astellas, AtraZeneca ,Bayer, BMS, Eisai, Ipsen, Janssen, Merck, Pfizer, Roche, SeaGen Tamim Nizai Honoraria/Research fun: Abbvie, Sanofi, TerSera,...

CUA Highlights of ESMO 2021 - Bladder Cancer Session - French 22.09.2021

Disclosures: Girish Kilkarni Advisory Boards: Janssen, Merck, Roche, Ferring, Astellas, Theralase Grants/Honoraria: Abbvie, Sanofi, Ferring, TerSera, Knight Therapeutics, Verity Clinical Trials: Merck, Astra Zeneca, Bristol Myers Squibb, Theralase, Janssen, Pfizer Krista Noonan Consulting/Honoraria: AstraZeneca, BMS, Janssen, Merck, Pfizer, EMD Serono Research Support: Roche

CUA Highlights of ESMO 2021 - Kidney Cancer Session - French 22.09.2021

Disclosures:   Michael Leveridge Ipsen - speaker session moderator 2019 Maryam Soleimani Honorarium: Pfizer Grant funding: Abbvie, Astellas, Bayer Himu Lukka No disclosures

CUA Highlights of ESMO 2021 - Kidney Cancer Session 22.09.2021

Disclosures:   Michael Leveridge Ipsen - speaker session moderator 2019 Maryam Soleimani Honorarium: Pfizer Grant funding: Abbvie, Astellas, Bayer Himu Lukka No disclosures

CUA Highlights of ESMO 2021 - Bladder Cancer Session 22.09.2021

Disclosures: Girish Kilkarni Advisory Boards: Janssen, Merck, Roche, Ferring, Astellas, Theralase Grants/Honoraria: Abbvie, Sanofi, Ferring, TerSera, Knight Therapeutics, Verity Clinical Trials: Merck, Astra Zeneca, Bristol Myers Squibb, Theralase, Janssen, Pfizer Krista Noonan Consulting/Honoraria: AstraZeneca, BMS, Janssen, Merck, Pfizer, EMD Serono Research Support: Roche

CUA Highlights of ESMO 2021 - Prostate Cancer Session 22.09.2021

Disclosures:   Sebastien J. Hotte Research Funding (Institution): Astellas, AstraZeneca, Ayala, Bayer, BMS, Eisai, Exelixis, Janssen, Ipsen, Merck, Roche, Sanofi, SeaGen, SignalChem Grants (Institution): BMS, Janssen, Bayer Consultant/Honoraria (Self): Astellas, AtraZeneca ,Bayer, BMS, Eisai, Ipsen, Janssen, Merck, Pfizer, Roche, SeaGen Tamim Nizai Honoraria/Research fun: Abbvie, Sanofi, TerSera,...

CUA Q & A Series | Topic: Delay of Injection 13.07.2021

Delay of Injection (Q&A series) 0:00 - Ricardo Rendon 9:30 - Fred Saad 18:10 - Jasper Yuen

Milestones in Advanced Bladder Cancer 12.07.2021

Podcast Host Disclosures: Dr. Alimohamed has had a consulting or advisory role with Astellas Pharma, AstraZeneca, Janssen, Merck, Pfizer, and Sanofi Canada. Dr. Lalani has received honoraria from Astellas Pharma, Bayer, Bristol-Myers Squibb, Merck, Novartis, Pfizer, Roche/Genentech, and TerSera; has had a consulting or advisory role with Abbvie, Astellas Pharma, Bayer, Bristol-Myers Squibb, Eisai,...

Słuchaj podcastu Canadian Urological Association (CUA) w Replaio

Radio i podcasty w jednej aplikacji - za darmo, bez zakładania konta. Zainstaluj już dziś i nie przegap premiery

Pobierz z Google Play

Replaio nie jest wydawcą podcastów; nazwy audycji, okładki i audio należą do ich autorów i są rozpowszechniane przez publiczne kanały RSS